Partial compliance with antipsychotic medication is common in patients with schizophrenia.
OBJECTIVE
Partial compliance with antipsychotic medication increases relapse and rehospitalization rates in patients with schizophrenia. The aim of the present study was to assess the frequency of and factors contributing to partial compliance.


METHODS
During a 10 day period in June 2004 psychiatrists working in hospitals or in private practices in Germany were asked to participate in a compliance survey. Physicians were requested to evaluate the compliance in 10 patients with schizophrenia using a questionnaire consisting of 10 questions. The frequency of unintentional and intentional partial compliance as well as patient-related contributing factors were assessed. Unintentional partial compliance was defined as the lack of drug intake on any day during the past month. Demographic data of participants were collected. Responses were analysed using descriptive statistics and generalized estimation equation models.


RESULTS
The psychiatrists (n=699) regarded 68% of the evaluated patients (n=5729) as unintentionally partially compliant within the last month. Sixty-nine per cent of the patients were considered intentionally partially compliant in the past. The most frequently assessed patient-related factors contributing to the partial compliance were lack of insight into the need for prophylactic medication (68%), lack of insight/denial of illness (66%/63%), feeling embarrassed at taking medication every day (62%), needing someone to remind them to take their medication (62%), cognitive problems (55%), and living conditions inappropriate for compliance (46%).


CONCLUSIONS
Partial compliance is a common problem in schizophrenia. Strategies to improve partial compliance derived from the contributing factors identified in the present study may include regular telephone reminders by case managers or families, adequate support in the patients' environment, use of dosette boxes, rationalizing drug regimens (e.g. once-daily dosage, monotherapy, depot medication), and psychoeducation.
Rummel-Kluge
Christine
C
Department and Clinic of Psychiatry and Psychotherapy, Technical University Munich, Munchen, Germany. christine.rummel@lrz.tum.de
Schuster
Tibor
T
Peters
Stefan
S
Kissling
Werner
W
D014150:Antipsychotic Agents / Q000008:administration & dosage*; D005858:Germany; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D033182:Intention; D010349:Patient Compliance / Q000523:psychology* / Q000706:statistics & numerical data*; D012008:Recurrence; D012307:Risk Factors; D012559:Schizophrenia / Q000188:drug therapy*; D012565:Schizophrenic Psychology; D011795:Surveys and Questionnaires
D014150:Antipsychotic Agents